Ten years after the approval of the first human papillomavirus (HPV) vaccine, vaccination rates in both males and females continue to fall short of the 80% coverage goals included in Healthy People 2020.1 In 2015, 62.8% of girls and 49.8% of boys aged 13 to 17 had received at least 1 dose of HPV vaccine, and 41.9% of female adolescents and 28.1% of male adolescents had completed the 3-dose series, according to the US Centers for Disease Control and Prevention.2 Although recent increases in HPV vaccination rates have been observed (perhaps a result of coordinated recent efforts by vaccination advocates to emphasize the role of these vaccines in cancer prevention) the identification of innovative approaches to promoting widespread use of HPV vaccines remains a priority.3
School vaccination requirements have long been viewed by proponents of vaccination as effective and essential tools in promoting and sustaining high...
Comments